학술논문
Cardiovascular Benefit of Empagliflozin across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME Trial
Document Type
Article
Author
Source
In: Journal of Clinical Endocrinology and Metabolism . (Journal of Clinical Endocrinology and Metabolism, 1 September 2020, 105(9):3025-3035)
Subject
Language
English
ISSN
19457197
0021972X
0021972X